Skip to main content
Premium Trial:

Request an Annual Quote

Perhaps There Are Better Ways to Spend the Money

It's not just financial firms that are being looked at askance over the pay of executives and board members -- biotech companies are also feeling the heat, reports the Wall Street Journal. An article in the June issue of Nature Biotechnology analyzed the salaries of 51 UK biotech companies, finding the average compensation for a chief executive to be £297,947 (US$493,616), and noting that higher pay didn't necessarily track with better performance. "There are quite a number of companies paying really quite substantial sums to CEOs and board members when they have very poor prospects. It cannot be helpful for the companies to have people draining cash out of them in this way," says study author William Bains from the University of Cambridge.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.